gene_symbol
CD3E
hgnc_id
HGNC:1674
binding_type
antigen recognition
cytotoxicity
NO
cytotoxicity_type
INDIRECT
cytotoxicity_mechanism
Blinatumomab binds CD3ε on T cells to recruit/activate them to kill CD19+ B cells; the CD3ε+ T cells are not killed. Killing occurs via T cell perforin/granzyme after immune synapse formation against CD19-expressing targets.
enzyme_product
Off
epitope
On
variant
Off
isoform
Off
hla_specific
Off
gated
Off
other_modifier
T-cell CD3 complex subunit
trial_id_tar_ref
drug_id_tar_ref
disease_id_tar_ref
nct_id_tar_ref
NCT06257394
disease_id_num_tar_ref
1696
drug_id_num_tar_ref
4592